Evidence map›Paper›PMID 32547205›Full record

ArticleCancer management and research2020

The Effect of Hormone Therapy on the Expression of Prostate Cancer and Multi-Epigenetic Marker Genes in a Population of Iranian Patients.

Mahan Mohammadi, Shiva Irani, Iman Salahshourifar, Jalil Hosseini, Afshin Moradi, Farkhondeh Pouresmaeili

Open access · goldAbstract read
In one paragraph

Article in Cancer management and research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. RASSF1A and its epigenetic dysregulation in genitourinary cancer: a current update.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Article
  3. Article
  4. Epigenetics in prostate cancer treatment.Journal of translational genetics and genomics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mahan MohammadiDepartment of Molecular Genetics, Faculty of Science, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Shiva IraniDepartment of Molecular Genetics, Faculty of Science, Science and Research Branch, Islamic Azad University, Tehran, Iran.ORCID 0000-0002-4202-9931
Iman SalahshourifarDepartment of Molecular Genetics, Faculty of Science, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Jalil HosseiniMen's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Afshin MoradiDepartment of Pathology, Shahid Beheshti University of Medical Sciences, Shohadaye Tajrish Hospital, Tehran, Iran.ORCID 0000-0003-1544-0992
Farkhondeh PouresmaeiliMen's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Islamic Azad University, Science and Research Branch · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimMany recent studies have shown a direct relationship between the decrease in the expression of PATIENTS AND

methodsIn this case-control study, 35 prostate cancer samples were examined before and after hormone therapy. Following the blood sampling, RNA extraction, and cDNA synthesis, the expression of

resultsThe results analysis showed that the expression of DISCUSSION: Significant changes in the expression of

Indexed as

DNMT3ADNMT3BGSTP1HDAChormone therapyprostate cancerRASSF1real-time PCR

Identifiers

PMID32547205
PMCPMC7245437
OpenAlexW3025007645

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.